Hazem F. M. Abdelaal

Seattle Children's Hospital — United States

Medicine · Health Sciences

5h-index184citations27works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(11), Mycobacterium research and diagnosis(11), Monoclonal and Polyclonal Antibodies Research(3), Immune Cell Function and Interaction(3), vaccines and immunoinformatics approaches(3)

Publications27 total

Comparative transcriptomic signatures of virulent and attenuated Mycobacterium bovis growing in vitro and in mice
Frontiers in Cellular and Infection Microbiology·2025Open Access
Robust Lane Detection under Varying Lighting Conditions Using Adaptive Vision-Based Techniques
Journal of Informatics and Web Engineering·2025Open Access
Intradermal Inoculation of <em>Mycobacterium avium</em> in the Mouse Ear
Journal of Visualized Experiments·2025Open Access
Review 2: "Immunopeptidomics Informs Discovery and Delivery of Mycobacterium Tuberculosis MHC-II Antigens for Vaccine Design"
2025Open Access
Reviews of "Immunopeptidomics Informs Discovery and Delivery of Mycobacterium Tuberculosis MHC-II Antigens for Vaccine Design"
2025Open Access
Evaluation of host immune responses to Mycobacteriophage Fionnbharth by route of delivery
Virology Journal·2025· 4 citedOpen Access
Assessment of tuberculosis drug efficacy using preclinical animal models and in vitro predictive techniques
npj Antimicrobials and Resistance·2024· 2 citedOpen Access
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent
mSphere·2024· 1 citedOpen Access
Reviewer response for version 1
2024Open Access
The chosen few: Mycobacterium tuberculosis isolates for IMPAc-TB
UNC Libraries·2024Open Access
The chosen few: Mycobacterium tuberculosis isolates for IMPAc-TB
Frontiers in Immunology·2024· 4 citedOpen Access
Reviewer response for version 2
2024Open Access
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent
2024Open Access
Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming
Frontiers in Immunology·2024· 4 citedOpen Access
E3 ubiquitin ligase CBLB regulates innate immune responses and bacterial dissemination during nontuberculous mycobacteria infection
Journal of Leukocyte Biology·2024Open Access
SARS-CoV-2 infection and immune responses
AIMS Microbiology·2023· 21 citedOpen Access
Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen
Tuberculosis·2022· 19 citedOpen Access
Mycobacterium abscessus: It’s Complex
Microorganisms·2022· 52 citedOpen Access
Uncovering the role of CBLB for innate immune responses regulating systemic dissemination during a Non-Tuberculous Mycobacterial infection
The Journal of Immunology·2021
Decoding the role of CBLB for innate immune responses regulating systemic dissemination during Non-Tuberculous Mycobacteria infection
2020Open Access
page 1 of 2Next →

Frequent Co-authors

Rhea N. Coler(11), Susan L. Baldwin(10), Sasha E. Larsen(9), Adel M. Talaat(5), Matthew H. Harband(5), Bryan J. Berube(4), Debora Ferede(3), Tiffany Pecor(3), Brendan K. Podell(3), Brittany D. Williams(3), Jaishree Sharma(3), Srinivasu Mudalagiriyappa(3), Thomas C. Kelly(3), Woosuk Choi(3), Miranda D. Vieson(3), Som G. Nanjappa(3), Essam Nasr(2), Howard Steinberg(2), Valerie A. Reese(2), Darlene Miller(2)